PRLD logo

Prelude Therapeutics Incorporated

PRLD
Healthcare|Biotechnology|US
$3.60
+0.04 (+1.27%)
DCF Value
$3.79
Tangible Book / Share
$1.36
Cash / Share
$1.54
Next Earnings Report
Nov 11, 2026
EPS est. $0.01 · Revenue est. $29.0M
Financing Filings (last 12 months)
3
Shelf registrations / offering prospectuses — latest Apr 21, 2026 (424B5). Possible dilution.

Upcoming Data Readouts (1)

Apr 2028
Est. completion
P1Polycythemia Vera (PV)
A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
NCT07469891n=100

Recent Press Releases

Prelude Therapeutics to Participate in the Chardan Healthcare Conference
Oct 16, 2026 · GlobeNewsWire
Prelude Announces Clinical Trial Collaboration and Supply Agreement with Lilly to Evaluate KAT6A Selective Degrader PRT13722 in Combination with Verzenio® and Inluriyo® in Patients with HR+/HER2- Breast Cancer
Oct 13, 2026 · GlobeNewsWire
Prelude Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Sep 11, 2026 · GlobeNewsWire
Prelude Therapeutics Receives FDA Clearance of Investigational New Drug (IND) Application for PRT13722, Its First-in-Class Oral KAT6A Selective Degrader
Sep 10, 2026 · GlobeNewsWire

SEC Filings (52)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Sep 10, 20268-KMaterial eventDocumentIndex
Aug 11, 202610-QQuarterly reportDocumentIndex
Aug 11, 20268-KMaterial eventDocumentIndex
Jul 8, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jun 10, 20268-KMaterial eventDocumentIndex
May 12, 202610-QQuarterly reportDocumentIndex
May 12, 20268-KMaterial eventDocumentIndex
Apr 29, 2026ARSAnnual report to holdersDocumentIndex
Apr 29, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 29, 2026DEF 14AProxy / shareholder voteDocumentIndex
Apr 28, 2026SC 13GPassive 5%+ stakeDocumentIndex
Apr 23, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Apr 22, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Apr 21, 20268-KMaterial eventDocumentIndex
Apr 21, 2026424B5Offering prospectusDocumentIndex
Apr 20, 20268-KMaterial eventDocumentIndex
Apr 15, 20268-KMaterial eventDocumentIndex
Mar 12, 20268-KMaterial eventDocumentIndex
Mar 12, 2026424B5Offering prospectusDocumentIndex
Mar 10, 2026S-8Employee stock planDocumentIndex
Mar 10, 202610-KAnnual reportDocumentIndex
Mar 10, 20268-KMaterial eventDocumentIndex
Feb 13, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 3, 20268-KMaterial eventDocumentIndex
Jan 9, 20268-KMaterial eventDocumentIndex
Dec 16, 2025EFFECTDocumentIndex
Dec 10, 2025S-3Shelf registrationDocumentIndex
Nov 12, 202510-QQuarterly reportDocumentIndex
Nov 12, 20258-KMaterial eventDocumentIndex
Nov 7, 2025SC 13GPassive 5%+ stakeDocumentIndex
Nov 4, 20258-KMaterial eventDocumentIndex
Oct 17, 20258-KMaterial eventDocumentIndex
Sep 19, 20258-KMaterial eventDocumentIndex
Aug 14, 202510-QQuarterly reportDocumentIndex
Aug 14, 20258-KMaterial eventDocumentIndex
Jun 13, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Jun 13, 20258-KMaterial eventDocumentIndex
May 15, 2025SC 13G/APassive 5%+ stakeDocumentIndex
May 6, 202510-QQuarterly reportDocumentIndex
May 6, 20258-KMaterial eventDocumentIndex